4.6 Article

Decreased pathology and prolonged survival of human DC-SIGN transgenic mice during mycobacterial infection

Journal

JOURNAL OF IMMUNOLOGY
Volume 180, Issue 10, Pages 6836-6845

Publisher

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.180.10.6836

Keywords

-

Categories

Funding

  1. PHS HHS [HHSN 266200400091C] Funding Source: Medline

Ask authors/readers for more resources

Dendritic cell (DO-specific intercellular adhesion molecule-3 grabbing nonintegrin (DC-SIGN: CD209) is a C-type lectin that binds ICAM-2,3 and various pathogens such as HIV, helicobacter, and mycobacteria. It has been suggested that Mycobacterium tuberculosis, the causative agent of pulmonary tuberculosis, interacts with DC-SIGN to evade the immune system. To directly analyze the role of human DC-SIGN during mycobacterial infection, we generated conventional transgenic (tg) mice (termed hSIGN) using CD209 cDNA under the control of the murine CD11c promoter. Upon mycobacterial infection, DO from hSIGN mice produced significantly less IL-12p40 and no significant differences were be observed in the secretion levels of IL-10 relative to control DCs. After high dose aerosol infection with the strain M. tuberculosis H37Rv, hSIGN mice showed massive accumulation of DC-SIGN(+) cells in infected lungs, reduced tissue damage and prolonged survival. Based on our in vivo data, we propose that instead of favoring the immune evasion of mycobacteria, human DC-SIGN may have evolved as a pathogen receptor promoting protection by limiting tuberculosis-induced pathology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available